Antiva Biosciences

Acquisition, funding and merger involving Antiva Biosciences.

• Antiva Biosciences has just announced a $53 Million fundraising (posted on April 28 2023).

View the org chart displaying its 13 main executives

Most searched biographies at Antiva Biosciences

• Kristine Ball, President and Chief Executive Officer
• Jenny Yip, Director
• Florencia Segal, Director

Popular executive movements at Antiva Biosciences

• Susan Wilson has joined the company as Vice President of Project Management and Strategic Initiatives  (posted on October 19 2023).
• Rajashree Joshi-Hangal has joined the company as Vice President of Technical Operations  (posted on October 19 2023).
• Elaine Chien has joined the company as Chief Medical Officer  (posted on October 19 2023).

Create your alert
to follow the executive moves at Antiva Biosciences.

Antiva Biosciences has 2,290 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Delphia Therapeutics has just announced a $67 Million fundraising (posted on May 7 2024).
• Karius has just announced a $100 Million fundraising (posted on May 3 2024).
• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Antiva Biosciences

• Antiva Press Release
• Antiva Press Release
• Antiva Press Release
• Antiva Press Release

Social media about Antiva Biosciences

• Antiva Biosciences on Wikipedia, Google News & Yahoo Finance
• Antiva Biosciences on LinkedIn, Twitter & YouTube

Contact by email its executives including Wende Hutton

Call Antiva Biosciences at +1 650...

View the org chart

Register to receive your alert

Report an error